PATENT CLAIM ANALYSIS

Application Number: 16206395
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "248000"]

Abstract:
The present application provides novel pyrimido-pyridazinone compounds and methods for preparing and using these compounds. These compounds are useful in treating inflammation in patients by administering one or more of the compounds to a patient. In one embodiment, the novel pyrimido-pyridazinone compound is of Formula (I) and R 1  and R 2  are defined herein.

Claim (Index 22):
The compound according to  claim 21 , wherein said acid is selected from the group consisting of acetic, propionic, lactic, citric, tartaric, succinic, fumaric, maleic, malonic, mandelic, malic, phthalic, hydrochloric, hydrobromic, phosphoric, nitric, sulfuric, methanesulfonic, napthalenesulfonic, benzenesulfonic, toluenesulfonic, trifluoroacetic, and camphorsulfonic.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 98.0
- Lexical Diversity: 1.35556
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13592511', '15137950', '14244183', '13552876', '15645775']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8304735104451988
- 35 USC 102 Novelty (BERT): 0.6512244251377505
- Combined Prediction Score: 0.812548601914454
- Mean Citation Score: 501.49154000000016
- Max Citation Score: 609.8373
- Similarity Product: 603.6709235830842

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test